Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol, in Mild Asthma

NCT01804218 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Mild Persistent Asthma, Uncomplicated

Interventions

DRUG: Nadolol
DRUG: Placebo

Sponsor

Invion, Inc.